CLBT logo

Cellebrite DI Ltd. Stock Price

NasdaqGS:CLBT Community·US$4.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 34 Fair Values set on narratives written by author

CLBT Share Price Performance

US$18.11
-0.38 (-2.08%)
21.8% undervalued intrinsic discount
US$23.14
Fair Value
US$18.11
-0.38 (-2.08%)
21.8% undervalued intrinsic discount
US$23.14
Fair Value
Price US$18.11
AnalystConsensusTarget US$23.14
AnalystLowTarget US$18.00
AnalystHighTarget US$28.00

CLBT Community Narratives

AnalystConsensusTarget·
Fair Value US$23.14 21.8% undervalued intrinsic discount

Cloud SaaS Solutions Will Drive Digital Forensics Adoption

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AnalystLowTarget·
Fair Value US$18 0.6% overvalued intrinsic discount

Government Delays Will Limit Digital Forensics Efficacy But Boost Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$28 35.3% undervalued intrinsic discount

Digital Device Growth And Cybercrime Will Transform Investigations

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$28
35.3% undervalued intrinsic discount
Revenue growth
18.93% p.a.
Profit Margin
28.14%
Future PE
54.88x
Share price in 2028
US$37.88
US$18
0.6% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
15.51% p.a.
Profit Margin
21.82%
Future PE
49.67x
Share price in 2028
US$24.36

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
2 Rewards

Cellebrite DI Ltd. Key Details

US$436.7m

Revenue

US$68.2m

Cost of Revenue

US$368.5m

Gross Profit

US$519.4m

Other Expenses

-US$150.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.62
84.38%
-34.56%
0%
View Full Analysis

About CLBT

Founded
1999
Employees
1167
CEO
Thomas Hogan
WebsiteView website
www.cellebrite.com

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company’s digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.

Recent CLBT News & Updates

What Cellebrite DI Ltd.'s (NASDAQ:CLBT) 26% Share Price Gain Is Not Telling You

Sep 09
What Cellebrite DI Ltd.'s (NASDAQ:CLBT) 26% Share Price Gain Is Not Telling You

Recent updates

No updates